• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Gen Virol. Antigenicity and transmissibility of a novel clade 2.3.2.1 avian influenza H5N1 virus.

Giuseppe

Emeritus


[Source: US National Library of Medicine, full page: (LINK). Abstract, edited.]

J Gen Virol. 2013 Dec;94(Pt 12):2616-26. doi: 10.1099/vir.0.057778-0. Epub 2013 Sep 28.

Antigenicity and transmissibility of a novel clade 2.3.2.1 avian influenza H5N1 virus.

Xu L, Bao L, Yuan J, Li F, Lv Q, Deng W, Xu Y, Yao Y, Yu P, Chen H, Yuen KY, Qin C.

Author information: Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences & Comparative Medicine Center, Peking Union Medical College; Key Laboratory of Human Disease Comparative Medicine, Ministry of Health; Key Laboratory of Animal Models of Human Diseases, State Administration of Traditional Chinese Medicine, Beijing, 100021, China.


Abstract

A genetic variant of the H5N1 influenza virus, termed subclade 2.3.2.1, was first identified in Bulgaria in 2010 and has subsequently been found in Vietnam and Laos. Several cases of human infections with this virus have been identified. Thus, it is important to understand the antigenic properties and transmissibility of this variant. Our results showed that, although it is phylogenetically closely related to other previously characterized clade 2.3 viruses, this novel 2.3.2.1 variant exhibited distinct antigenic properties and showed little cross-reactivity to sera raised against other H5N1 viruses. Like other H5N1 viruses, this variant bound preferentially to avian-type receptors, but contained substitutions at positions 190 and 158 of the haemagglutinin (HA) protein that have been postulated to facilitate HA binding to human-type receptors and to enhance viral transmissibility among mammals, respectively. However, this virus did not appear to have acquired the capacity for airborne transmission between ferrets. These findings highlight the challenges in selecting vaccine candidates for H5N1 influenza because these viruses continue to evolve rapidly in the field. It is important to note that some variants have obtained mutations that may gain transmissibility between model animals, and close surveillance of H5N1 viruses in poultry is warranted.


PMID: 24077367 [PubMed - indexed for MEDLINE]


 
Back
Top Bottom